Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$858M |
| 2 |
Costco
COST
|
+$557M |
| 3 |
UnitedHealth
UNH
|
+$551M |
| 4 |
Atlassian
TEAM
|
+$489M |
| 5 |
Northrop Grumman
NOC
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$579M |
| 2 |
TSMC
TSM
|
+$433M |
| 3 |
Airbnb
ABNB
|
+$426M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$341M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$231M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.22% |
| 2 | Consumer Discretionary | 23.3% |
| 3 | Healthcare | 16.47% |
| 4 | Financials | 9.42% |
| 5 | Communication Services | 7.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
Nurix Therapeutics
NRIX
$2.41B
| $563K | ﹤0.01% |
43,181
-553
| -1% | -$8.75K |
|
577
Nexstar Media Group
NXST
$5.82B
| $551K | ﹤0.01% |
+3,304
| New | +$612K |
|
|
FISV
578
Fiserv Inc
FISV
$28.8B
| $548K | ﹤0.01% |
+5,857
| New | +$597K |
|
579
HP
HPQ
$24.9B
| $548K | ﹤0.01% |
+21,996
| New | +$676K |
|
580
DigitalBridge
DBRG
$2.93B
| $541K | ﹤0.01% |
+43,272
| New | +$833K |
|
581
UWM Holdings
UWMC
$617M
| $541K | ﹤0.01% |
+184,690
| New | +$680K |
|
582
H&R Block
HRB
$5.58B
| $534K | ﹤0.01% |
+12,563
| New | +$532K |
|
583
Deckers Outdoor
DECK
$13.2B
| $521K | ﹤0.01% |
10,002
-3,966
| -28% | -$206K |
|
584
Opendoor
OPEN
$3.64B
| $515K | ﹤0.01% |
+171,201
| New | +$786K |
|
585
Vanguard Morningstar Growth ETF
VUG
$225B
| $479K | ﹤0.01% |
13,422
-5,124
| -28% | -$206K |
|
586
Cardlytics
CDLX
$21.7M
| $474K | ﹤0.01% |
5,047
-68,683
| -93% | -$9.78M |
|
587
iShares North American Natural Resources ETF
IGE
$748M
| $459K | ﹤0.01% |
13,210
+2,842
| +27% | +$106K |
|
588
Coca-Cola
KO
$377B
| $459K | ﹤0.01% |
8,194
-28,639
| -78% | -$1.78M |
|
589
SkinHealth Systems
SKIN
$88.8M
| $438K | ﹤0.01% |
37,151
+2,754
| +8% | +$34.8K |
|
590
United Therapeutics
UTHR
$22B
| $438K | ﹤0.01% |
2,091
-6,336
| -75% | -$1.42M |
|
591
Carvana
CVNA
$68.6B
| $435K | ﹤0.01% |
+107,200
| New | +$699K |
|
592
Welltower
WELL
$169B
| $420K | ﹤0.01% |
6,533
| – | – |
|
593
Morningstar
MORN
$7.22B
| $401K | ﹤0.01% |
1,890
-884
| -32% | -$210K |
|
594
Toast
TOST
$18.7B
| $382K | ﹤0.01% |
+22,858
| New | +$396K |
|
595
MongoDB
MDB
$27.1B
| $342K | ﹤0.01% |
1,720
+37
| +2% | +$10.8K |
|
596
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.7B
| $301K | ﹤0.01% |
750
+102
| +16% | +$45.1K |
|
597
Alkami Technology
ALKT
$1.94B
| $281K | ﹤0.01% |
+18,644
| New | +$272K |
|
598
Equinor
EQNR
$97.7B
| $278K | ﹤0.01% |
+8,393
| New | +$303K |
|
599
Mettler-Toledo International
MTD
$28.6B
| $202K | ﹤0.01% |
+186
| New | +$231K |
|
600
Alcoa
AA
$11.9B
| – | – |
-96,187
| Closed | -$4.38M |
|
Similar funds
Jennison Associates's Q3 2022 Portfolio in Review
As of Q3 2022, Jennison Associates held 689 positions worth $101B, up 0.37% from $100B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Jennison Associates's Q3 2022 filing shows 75 new, 294 increased, 218 reduced and 90 closed positions. Its largest new stake was T-Mobile US: 1,657,443 shares worth $222M. The largest sale was Nike, an estimated $579M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Jennison Associates's largest Q3 2022 buy was T-Mobile US: 1,657,443 shares worth $222M.
- Jennison Associates added most to Vertex Pharmaceuticals in Q3 2022, an estimated $858M increase.
- Jennison Associates's biggest Q3 2022 reduction was Nike, cutting an estimated $579M.
- Jennison Associates fully exited Snap in Q3 2022, selling an estimated $197M.
- Jennison Associates's ten largest holdings make up 40% of its $101B portfolio in Q3 2022.
- Jennison Associates opened 75 new positions and closed 90 in Q3 2022.
- Jennison Associates's portfolio value rose 0.37% quarter-over-quarter to $101B.
Based on Jennison Associates's 13F filing for Q3 2022, filed 1 Nov 2022.